Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma

Experimental and Molecular Medicine

Volumn 43, Issue 11, 2011, Pages 622-629

  Yang, Hee Seok ^a   Shin, Jaehoon ^a   Bhang, Suk Ho ^a   Shin, Jung Youn ^a   Park, Jooyeon ^a   Im II, Gun ^b   Kim, Chang Sung ^c   Kim, Byung Soo ^a  

^a Seoul National University   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Yonsei University College of Dentistry   (South Korea)

Author keywords

Angiogenesis inducing agents; Endothelial growth factors; Fibrin; Fibroblast growth factor 2; Heparin; Neovascularization; Physiologic; Platelet rich plasma; Plateletderived growth factor; Wound healing

Indexed keywords

CALCIUM CHLORIDE; FIBRIN; FIBROBLAST GROWTH FACTOR 2; HEPARIN CONJUGATED FIBRIN; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HISTOLOGY; HUMAN; MOUSE; NONHUMAN; PROTEIN SECRETION; SKIN FIBROBLAST; SKIN INJURY; SKINFOLD THICKNESS; THROMBOCYTE RICH PLASMA; TISSUE REPAIR; WOUND CLOSURE; WOUND HEALING;

EID: 81855201882     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2011.43.11.070     Document Type: Article

References (34)

1. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005;31:674-86; discussion 686
2. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81
3. Bhang SH, Sun AY, Yang HS, Rhim T, Kim DI, Kim BS. Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin. Biotechnol Lett 2011;33:845-51
4. Bir SC, Esaki J, Marui A, Yamahara K, Tsubota H, Ikeda T, Sakata R. Angiogenic properties of sustained release platelet-rich plasma: characterization in vitro and in the ischemic hind limb of the mouse. J Vasc Surg 2009;50:870-9 e2
5. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996;85:683-93
6. Chu CL, Buczek-Thomas JA, Nugent MA. Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J 2004;379:331-41
7. Davidson J, Buckley A, Woodward S, Nichols W, McGee G, Demetriou A. Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factor. Prog Clin Biol Res 1988;266:63-75
8. Enenstein J, Waleh NS, Kramer RH. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992;203:499-503
9. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005;84:434-9
10. Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 2002;22:45-53
11. Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990;95:626-31
12. Hokugo A, Ozeki M, Kawakami O, Sugimoto K, Mushimoto K, Morita S, Tabata Y. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 2005;11:1224-33
13. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 2001;108:349-55
14. Jeon O, Kang SW, Lim HW, Hyung Chung J, Kim BS. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 2006;27:1598-607
15. Kim S, Oh JH, Lee Y, Lee J, Cho KH, Chung JH. Induction of tissue inhibitor of matrix metalloproteinase-2 by cholesterol depletion leads to the conversion of proMMP-2 into active MMP-2 in human dermal fibroblasts. Exp Mol Med 2010;42:38-46
16. Marui A, Kanematsu A, Yamahara K, Doi K, Kushibiki T, Yamamoto M, Itoh H, Ikeda T, Tabata Y, Komeda M. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 2005;41:82-90
17. McCawley LJ, O'Brien P, Hudson LG. Epidermal growth factor (EGF)-and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 1998;176:255-65
18. Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997;15:180-9
19. Raghoebar GM, Schortinghuis J, Liem RS, Ruben JL, van der Wal JE, Vissink A. Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor? Clin Oral Implants Res 2005;16:349-56
20. Raza SL, Cornelius LA. Matrix metalloproteinases: pro-and anti-angiogenic activities. J Investig Dermatol Symp Proc 2000;5:47-54
21. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007;16:156-65
22. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-46
23. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17:153-62
24. Scott G, Stoler M, Sarkar S, Halaban R. Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J Invest Dermatol 1991;96:318-22
25. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996;149:293-305
26. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 1997;94:13612-7
27. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46
28. Tharakan S, Pontiggia L, Biedermann T, Bottcher-Haberzeth S, Schiestl C, Reichmann E, Meuli M. Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells. Pediatr Surg Int 2010;26:71-7
29. Thomopoulos S, Das R, Sakiyama-Elbert S, Silva MJ, Charlton N, Gelberman RH. bFGF and PDGF-BB for tendon repair: controlled release and biologic activity by tendon fibroblasts in vitro. Ann Biomed Eng 2010;38:225-34
30. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000;5:40-6
31. Tsay RC, Vo J, Burke A, Eisig SB, Lu HH, Landesberg R. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg 2005;63:521-8
32. Yang HS, Bhang SH, Hwang JW, Kim DI, Kim BS. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. Tissue Eng Part A 2010a;16:2113-9
33. Yang HS, La WG, Bhang SH, Jeon JY, Lee JH, Kim BS. Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Eng Part A 2010b;16:1225-33
34. Zhao B, Katagiri T, Toyoda H, Takada T, Yanai T, Fukuda T, Chung UI, Koike T, Takaoka K, Kamijo R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 2006;281:23246-53